Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPEX/4123 stock hub

TPEX/4123 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4123is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

28.3B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4123

In the news

Latest news · TPEX/4123

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E3.3

P25 14.4P50 18P75 31.9

ROE41.9

P25 -16.2P50 0.3P75 9.8

ROIC-1.1

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4123 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

216

Groups with data

Currency

TWD

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 32.4B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0004123005
Last refreshed	2026-05-10
Market cap	TWD 28.3B
Price	TWD 37.95
Price currency	TWD
Sector	Healthcare
Sic	2834
Symbol	tpex/4123
Website	https://www.centerlab.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	32.91%
EV Earnings	3.47x
EV/FCF	-181.52x
EV/Sales	21.35x
FCF yield	-0.63%
P/B ratio	1.07x
P/E ratio	3.32x
P/S ratio	18.69x
PE Ratio10 Y	83.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-23.85%
EBITDA Margin	-13.25%
Gross margin	40.97%
Gross Profit	TWD 621.3M
Gross Profit Growth	-17.05%
Gross Profit Growth Q	-20.64%
Gross Profit Growth3 Y	15.21%
Gross Profit Growth5 Y	12.14%
Net Income	TWD 9.3B
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Net Income Growth3 Y	350.14%
Net Income Growth5 Y	19.75%
Pretax Margin	763.01%
Profit Margin	614.89%
Profitable Years	1
ROA	-0.75
Roa5y	0.02
ROCE	-1.16
ROE	41.86
Roe5y	7.65
ROIC	-1.09
Roic5y	0.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.21%
Cagr15y	9.43%
Cagr1y	14.43%
Cagr20y	16.72%
Cagr3y	-3.61%
Cagr5y	-0.18%
Div CAGR3	-28.8%
Div CAGR5	-4.95%
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	323.2
EPS Growth5 Y	15.15
FCF Growth Q	-74.83%
OCF Growth	-93.12%
OCF Growth Q	-44.79%
Revenue Growth	-6.29x
Revenue Growth Q	-10.93x
Revenue Growth Years	0x
Revenue Growth3 Y	25.46x
Revenue Growth5 Y	16.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.05
Assets	TWD 34.6B
Cash	TWD 662.8M
Current Assets	TWD 1.6B
Current Liabilities	TWD 3.5B
Debt	TWD 4.7B
Debt Equity	TWD 0.18
Debt FCF	TWD -26.38
Equity	TWD 26.5B
Interest Coverage	-1.98
Liabilities	TWD 8.1B
Long Term Assets	TWD 33B
Long Term Liabilities	TWD 4.6B
Net Cash	TWD -4B
Net Cash By Market Cap	TWD -14.26
Net Debt Equity	TWD 0.15
Tangible Book Value	TWD 25.8B
Tangible Book Value Per Share	TWD 34.5
WACC	5.51

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.45
Inventory Turnover	2.7
Net Working Capital	TWD 347.8M
Quick ratio	0.26
Working Capital	TWD -1.9B
Working Capital Turnover	TWD -1.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.19%
Dividend Growth	-44.15%
Dividend Growth Years	0%
Dividend per share	TWD 0.71
Dividend Years	8
Dividend Yield	1.88%
Ex Div Date	2025-10-03
Last Dividend	TWD 0.76
Payout Frequency	Annual
Payout Ratio	5.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	50.99%
1Y total return	14.42%
200-day SMA	38.36
3Y total return	-10.45%
50-day SMA	41.79
50-day SMA vs 200-day SMA	50over200
5Y total return	-0.91%
All Time High	64.21
All Time High Change	-40.9%
All Time High Date	2020-07-13
All Time Low	1.97
All Time Low Change	1,827.37%
All Time Low Date	2006-09-11
ATR	0.95
Beta	0.3
Beta1y	-0.09
Beta2y	0.26
Ch YTD	-8.77
High	38.45
High52	51.4
High52 Date	2026-03-05
High52ch	-26.17%
Low	37.6
Low52	33.1
Low52 Date	2025-10-29
Low52ch	14.65%
Ma50ch	-9.19%
Price vs 200-day SMA	-1.08%
RSI	34.37
RSI Monthly	46.45
RSI Weekly	46.26
Sharpe ratio	0.59x
Sortino ratio	1.17
Total Return	-8.31%
Tr YTD	-8.77
Tr15y	286.44%
Tr1m	-7.33%
Tr1w	-2.06%
Tr3m	-3.68%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -361.6M
Operating margin	-23.85

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	561,963,196%
Net Borrowing	-1,959,328,000
Shares Insiders	2.1%
Shares Institutions	6.82%
Shares Out	746,533,000
Shares Qo Q	0.6%
Shares Yo Y	10.19%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -185.5M
Average Volume	2,659,743.75x
Bv Per Share	35.48
CAPEX	TWD -205.5M
Ch10y	24.33
Ch15y	218.2
Ch1m	-7.33
Ch1w	-2.06
Ch1y	12.16
Ch20y	1,714.1
Ch3m	-3.68
Ch3y	-16.36
Ch5y	-13.02
Ch6m	9.68
Change	-0.39%
Change From Open	-0.78
Close	38.1
Days Gap	0.39
Depreciation Amortization	160,690,000
Dollar Volume	82,649,521.4
Earnings Date	2026-04-02
EBIT	TWD -361.6M
EBITDA	TWD -200.9M
EPS	TWD 11.44
F Score	3
FCF	TWD -178.3M
FCF EV Yield	-0.55x
FCF Per Share	TWD -0.24
Financing CF	-2,884,806,000
Fiscal Year End	December
Founded	1,959
Goodwill	398,359,000
Graham Number	95.56687
Graham Upside	151.8
Income Tax	TWD 2.2B
Investing CF	1,652,892,000
Is Primary Listing	1
Last Earnings Date	2025-11-12
Last Report Date	2025-12-31
Last Split Date	2025-10-03
Last Split Type	Forward
Lynch Fair Value	TWD 226
Lynch Upside	495.3
Ma150	39.08
Ma150ch	-2.89%
Ma20	39.5
Ma20ch	-3.91%
Net CF	-1,204,711,000
Open	38.25
P OCF Ratio	1,043
Payment Date	2025-11-10
Position In Range	41.18
Ppne	1,848,071,000
Price Date	2026-05-08
Ptbv Ratio	1.1
Relative Volume	0.79x
Revenue	1,516,190,000x
SBC By Revenue	0.47x
Share Based Comp	7,153,000
Tax By Revenue	148.12x
Tax Rate	19.41%
Tr20y	2,103.02%
Tr6m	9.68%
Volume	2,177,853
Z Score	2.55

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/4123 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.9%

$0.71 annual per share

Payout ratio

+5.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-5.0%

0 consecutive years of growth

Total shareholder yield

-8.3%

Next ex-dividend date: 2025-10-03

Performance

TPEX/4123 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4123?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.8%

Share of float held by funds and institutions

Insider ownership

+2.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+10.2%

Negative means the company is buying back shares.

Technical

TPEX/4123 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.4

Neutral momentum band

Price vs 200-day MA

-1.1%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

0.59

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4123

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4123 stock rating?

tpex/4123 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4123 analysis?

The full report lives at /stocks/tpex/4123/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4123?

The latest report frames tpex/4123 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4123 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.